Levels of vasopressin in children undergoing cardiopulmonary bypass

Cardiology in the Young

Volumn 18, Issue 2, 2008, Pages 135-140

  Morrison, Wynne E ^a   Simone, Shari ^b   Conway, Dyana ^b   Tumulty, Jamie ^b   Johnson, Cynthia ^b   Cardarelli, Marcelo ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Maryland Hospital for Children   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Congenital heart surgery; Neurohormonal axis; Post cardiotomy shock

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPERTENSIVE AGENT; SODIUM; VASOPRESSIN;

ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CHILD CARE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; FEMALE; FLUID BALANCE; HORMONE DETERMINATION; HUMAN; HYPOTENSION; INFANT; MALE; OPERATION DURATION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; REFERENCE VALUE; RISK FACTOR; SERUM OSMOLALITY; SHOCK; SODIUM BLOOD LEVEL;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CORONARY ARTERY BYPASS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; VASOPRESSINS;

EID: 42049091504     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951108001881     Document Type: Article

References (23)

1. Vincent JL. Vasopressin in hypotensive and shock states. Crit Care Clin 2006; 22: 187-197.
2. Treschan TA, Peters J. The vasopressin system: Physiology and clinical strategies. Anesthesiology 2006; 105: 599-612.
3. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31: 1752-1758.
4. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595.
5. Argenzlano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998; 116: 973-980.
6. Argenziano M, Choudhri AF, Oz MC, Rose EA, Smith CR, Landry DW. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96: 286-290.
7. Barrett LK, Singer M, Clapp LH. Vasopressin: Mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007; 35: 33-40.
8. Landry DW, Oliver JA. Vasopressin and relativity: On the matter of deficiency and sensitivity. Crit Care Med 2006; 34: 1275-1277.
9. Pollack MM, Patel KM, Ruttimann UE. PRISM III: An updated Pediatric Risk of Mortality score. Crit Care Med 1996; 24: 743-752.
10. Zuppa AF, Nadkarni V, Davis L, et al. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med 2004; 32: 2318-2322.
11. Goldstein B, Giroir B, Randolph A. Values for systolic blood pressure: authors reply. Pediatr Crit Care Med 2005; 6: 500.
12. Kindelan A, Navero J, De la Rosa I, et al. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease. Crit Care Med 1994; 22: 1754-1761.
13. Jochberger S, Mayr VD, Luckner G, et al. Serum vasopressin concentrations in critically ill patients. Crit Care Med 2006; 34: 293-299.
14. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002; 123: 110-118.
15. Dunser MW, Lindner KH, Wenzel V. A century of arginine vasopressin research leading to new therapeutic strategies. Anesthesiology 2006; 105: 444-445.
16. Shu'ayb WA, Moran WH, Zimmerman B. Studies of the mechanism of antidiuretic hormone secretion and the post-commisurotomy dilutional syndrome. Ann Surg 1965; 162: 690-699.
17. Richardson RL, Giles H, Pate JW. Antidiuretic hormone secretion: Its relation to cardiac surgery and injury. J Tenn Med Assoc 1969; 62: 1126-1128.
18. Ationu A, Singer DR, Smith A, Elliott M, Burch M, Carter ND. Studies of cardiopulmonary bypass in children: Implications for the regulation of brain natriuretic peptide. Cardiovasc Res 1993; 27: 1538-1541.
19. Rosenzweig EB, Starc TJ, Chen JM, et al. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation, 1999; 100 (Suppl): II182-II186.
20. Boldt J, Menges T, Kuhn D, Diridis C, Hempelmann G. Alterations in circulating vasoactive substances in the critically ill-a comparison between survivors and non-survivors. Intensive Care Med 1995; 21: 218-225.
21. Lodha R, Vivekanandhan S, Sarthi M, Kabra SK. Serial circulating vasopressin levels in children with septic shock. Pediatr Crit Care Med 2006; 7: 220-224.
22. Killinger JS, Hsu DT, Hardart GE. The incidence of vasodilatory shock (VDS) in children after cardiopulmonary bypass (CPB). Crit Care Med 2006; 34: A61.
23. Albright TN, Zimmerman MA, Selzman CH. Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care 2002; 11: 326-330.